Dr. Tina Bhardwaj is a genomic medicine specialist and molecular diagnostics expert serving as Head—Oncogenomics in the Department of Molecular Genetics at LifeCell Diagnostics, a leading genomic- and molecular-testing provider in India that integrates next-generation sequencing and precision testing into preventive and oncology diagnostics. LifeCell Diagnostics combines advanced genomics with clinical insight to deliver comprehensive genetic testing and early molecular risk profiling across cancer and other health domains.

In her role, Dr. Bhardwaj leads oncogenomics initiatives that focus on evaluating tumor-associated genomic alterations, hereditary cancer risk panels, and targeted molecular tests that help clinicians tailor treatment strategies and improve diagnostic precision for cancer patients. Oncogenomics—the study of cancer-associated gene changes and molecular signatures—is increasingly central to personalized medicine, enabling identification of mutations and biomarkers that guide targeted therapies and prognosis.

She is also engaged in academic research; alongside her professional responsibilities she has been identified in scientific discourse on molecular pathology and genomic testing in India, including discussions on next-generation sequencing and personalised oncology testing. Her expertise contributes to elevating the role of advanced molecular diagnostics in the Indian healthcare landscape, particularly in expanding access to precision oncology that supports better treatment planning and patient outcomes.